392 related articles for article (PubMed ID: 23402116)
1. Immune responses and protection against H5N1 highly pathogenic avian influenza virus induced by the Newcastle disease virus H5 vaccine in ducks.
Ferreira HL; Pirlot JF; Reynard F; van den Berg T; Bublot M; Lambrecht B
Avian Dis; 2012 Dec; 56(4 Suppl):940-8. PubMed ID: 23402116
[TBL] [Abstract][Full Text] [Related]
2. Prime-boost vaccination with recombinant H5-fowlpox and Newcastle disease virus vectors affords lasting protection in SPF Muscovy ducks against highly pathogenic H5N1 influenza virus.
Niqueux E; Guionie O; Amelot M; Jestin V
Vaccine; 2013 Aug; 31(38):4121-8. PubMed ID: 23845804
[TBL] [Abstract][Full Text] [Related]
3. Maternal antibody inhibition of recombinant Newcastle disease virus vectored vaccine in a primary or booster avian influenza vaccination program of broiler chickens.
Bertran K; Lee DH; Criado MF; Balzli CL; Killmaster LF; Kapczynski DR; Swayne DE
Vaccine; 2018 Oct; 36(43):6361-6372. PubMed ID: 30241684
[TBL] [Abstract][Full Text] [Related]
4. Potency of a recombinant NDV-H5 vaccine against various HPAI H5N1 virus challenges in SPF chickens.
Lardinois A; Steensels M; Lambrecht B; Desloges N; Rahaus M; Rebeski D; van den Berg T
Avian Dis; 2012 Dec; 56(4 Suppl):928-36. PubMed ID: 23402114
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of a Recombinant Turkey Herpesvirus H5 Vaccine Against Challenge With H5N1 Clades 1.1.2 and 2.3.2.1 Highly Pathogenic Avian Influenza Viruses in Domestic Ducks (Anas platyrhynchos domesticus).
Pantin-Jackwood MJ; Kapczynski DR; DeJesus E; Costa-Hurtado M; Dauphin G; Tripodi A; Dunn JR; Swayne DE
Avian Dis; 2016 Mar; 60(1):22-32. PubMed ID: 26953940
[TBL] [Abstract][Full Text] [Related]
6. Stronger Interference of Avian Influenza Virus-Specific Than Newcastle Disease Virus-Specific Maternally Derived Antibodies with a Recombinant NDV-H5 Vaccine.
Lardinois A; Vandersleyen O; Steensels M; Desloges N; Mast J; van den Berg T; Lambrecht B
Avian Dis; 2016 May; 60(1 Suppl):191-201. PubMed ID: 27309055
[TBL] [Abstract][Full Text] [Related]
7. Pekin and Muscovy ducks respond differently to vaccination with a H5N1 highly pathogenic avian influenza (HPAI) commercial inactivated vaccine.
Cagle C; To TL; Nguyen T; Wasilenko J; Adams SC; Cardona CJ; Spackman E; Suarez DL; Pantin-Jackwood MJ
Vaccine; 2011 Sep; 29(38):6549-57. PubMed ID: 21771626
[TBL] [Abstract][Full Text] [Related]
8. Protective dose of a recombinant Newcastle disease LaSota-avian influenza virus H5 vaccine against H5N2 highly pathogenic avian influenza virus and velogenic viscerotropic Newcastle disease virus in broilers with high maternal antibody levels.
Sarfati-Mizrahi D; Lozano-Dubernard B; Soto-Priante E; Castro-Peralta F; Flores-Castro R; Loza-Rubio E; Gay-Gutiérrez M
Avian Dis; 2010 Mar; 54(1 Suppl):239-41. PubMed ID: 20521638
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of live and inactivated recombinant Newcastle disease virus vaccines expressing clade 2.3.4.4b H5 hemagglutinin against H5N1 highly pathogenic avian influenza in SPF chickens, Broilers, and domestic ducks.
Kim DH; Lee SH; Kim J; Lee J; Jeong JH; Kim JY; Song SU; Lee H; Cho AY; Hyeon JY; Youk S; Song CS
Vaccine; 2024 Jul; 42(18):3756-3767. PubMed ID: 38724417
[TBL] [Abstract][Full Text] [Related]
10. Comparison of single 1-day-old chick vaccination using a Newcastle disease virus vector with a prime/boost vaccination scheme against a highly pathogenic avian influenza H5N1 challenge.
Ferreira HL; Rauw F; Pirlot JF; Reynard F; van den Berg T; Bublot M; Lambrecht B
Avian Pathol; 2014; 43(1):68-77. PubMed ID: 24320551
[TBL] [Abstract][Full Text] [Related]
11. Level of protection of chickens against highly pathogenic H5 avian influenza virus with Newcastle disease virus based live attenuated vector vaccine depends on homology of H5 sequence between vaccine and challenge virus.
Römer-Oberdörfer A; Veits J; Helferich D; Mettenleiter TC
Vaccine; 2008 May; 26(19):2307-13. PubMed ID: 18395947
[TBL] [Abstract][Full Text] [Related]
12. Recombinant Turkey Herpesvirus-AI Vaccine Virus Replication in Different Species of Waterfowl.
Palya V; Kovács EW; Tatár-Kis T; Felföldi B; Homonnay ZG; Mató T; Sato T; Gardin Y
Avian Dis; 2016 May; 60(1 Suppl):210-7. PubMed ID: 27309057
[TBL] [Abstract][Full Text] [Related]
13. Differences in pathogenicity, response to vaccination, and innate immune responses in different types of ducks infected with a virulent H5N1 highly pathogenic avian influenza virus from Vietnam.
Cagle C; Wasilenko J; Adams SC; Cardona CJ; To TL; Nguyen T; Spackman E; Suarez DL; Smith D; Shepherd E; Roth J; Pantin-Jackwood MJ
Avian Dis; 2012 Sep; 56(3):479-87. PubMed ID: 23050463
[TBL] [Abstract][Full Text] [Related]
14. Vaccine protection of chickens against antigenically diverse H5 highly pathogenic avian influenza isolates with a live HVT vector vaccine expressing the influenza hemagglutinin gene derived from a clade 2.2 avian influenza virus.
Kapczynski DR; Esaki M; Dorsey KM; Jiang H; Jackwood M; Moraes M; Gardin Y
Vaccine; 2015 Feb; 33(9):1197-205. PubMed ID: 25613723
[TBL] [Abstract][Full Text] [Related]
15. Innovation in Newcastle Disease Virus Vectored Avian Influenza Vaccines.
Kim SH; Samal SK
Viruses; 2019 Mar; 11(3):. PubMed ID: 30917500
[TBL] [Abstract][Full Text] [Related]
16. Protective efficacy of Newcastle disease virus expressing soluble trimeric hemagglutinin against highly pathogenic H5N1 influenza in chickens and mice.
Cornelissen LA; de Leeuw OS; Tacken MG; Klos HC; de Vries RP; de Boer-Luijtze EA; van Zoelen-Bos DJ; Rigter A; Rottier PJ; Moormann RJ; de Haan CA
PLoS One; 2012; 7(8):e44447. PubMed ID: 22952980
[TBL] [Abstract][Full Text] [Related]
17. Protective efficacy of several vaccines against highly pathogenic H5N1 avian influenza virus under experimental conditions.
Veits J; Römer-Oberdörfer A; Helferich D; Durban M; Suezer Y; Sutter G; Mettenleiter TC
Vaccine; 2008 Mar; 26(13):1688-96. PubMed ID: 18291561
[TBL] [Abstract][Full Text] [Related]
18. Protective Efficacy of Recombinant Turkey Herpes Virus (rHVT-H5) and Inactivated H5N1 Vaccines in Commercial Mulard Ducks against the Highly Pathogenic Avian Influenza (HPAI) H5N1 Clade 2.2.1 Virus.
Kilany WH; Safwat M; Mohammed SM; Salim A; Fasina FO; Fasanmi OG; Shalaby AG; Dauphin G; Hassan MK; Lubroth J; Jobre YM
PLoS One; 2016; 11(6):e0156747. PubMed ID: 27304069
[TBL] [Abstract][Full Text] [Related]
19. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.
Pavlova SP; Veits J; Keil GM; Mettenleiter TC; Fuchs W
Vaccine; 2009 Jan; 27(5):773-85. PubMed ID: 19041677
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of an inactivated and a fowlpox-vectored vaccine in Muscovy ducks against an Asian H5N1 highly pathogenic avian influenza viral challenge.
Steensels M; Van Borm S; Lambrecht B; De Vriese J; Le Gros FX; Bublot M; van den Berg T
Avian Dis; 2007 Mar; 51(1 Suppl):325-31. PubMed ID: 17494576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
